SKIN - The Beauty Health Company Market Capitalization-to-Revenue Ratio

Symbol and logo of brand beautyhealth.com (SKIN)

While aggressive marketing through partnerships with hotels and spa centers expands reach, the workforce at The Beauty Health (SKIN) has stabilized following an R&D restructuring. The price-to-sales trend clearly demonstrates the market valuation, where the 0.40 mark captures this metric. Profit stability is ensured by the ownership of HydraFacial and the sale of high-cost consumables for installed equipment.

The Beauty Health - SKIN P/S Multiple (period 07/04/2022 - 11/15/2026)

beautyhealth.com (SKIN) - metric breakdowns and financial figures

- current quotes and average value forecast:
Summary company analytics:beautyhealth.com
Signature product of The Beauty Health

The P/S multiple compares the market value of The Beauty Health (SKIN) to its generated revenue, capturing daily shifts in investor expectations regarding business efficiency through closing price action. Analyzing this P/S chart reveals how the operational turnaround and the effort to resolve quality defects at The Beauty Health (SKIN) impact revenue valuation, helping investors avoid entering the asset ahead of a potential correction.

Who The Beauty Health competes with

HCA (HCA Healthcare) - Market Capitalization-to-Revenue Ratio|Tenet Healthcare Corporation - Market Cap to Revenue|Fresenius Medical (FMS) - Price to Sales|Solventum Corp - P/S Multiple|Price-to-Sales Ratio EHC|Universal Health Services (UHS) - Price-to-Revenue Ratio|DaVita - Market Capitalization-to-Revenue Ratio|Market Cap to Revenue RDNT|OPCH: Market Capitalization-to-Revenue Ratio|Market Cap to Revenue SGRY (Surgery Partners, Inc.)|PINC (Premier, Inc.) - Market Capitalization-to-Revenue Ratio|National Vision - Market Cap to Revenue|Price-to-Revenue Coefficient Progyny Inc (PGNY)|Ardent Health - P/S Multiple|Price-to-Revenue Coefficient Select Medical Corp SEM|ASTH: P/S Multiple|Market Cap to Revenue Ratio MD|USPH (US Physical Therapy Inc) - P/S Multiple|PNTG: Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Organogenesis Corp (ORGO)|NUTX (Nutex Health Corp) - Market Capitalization-to-Revenue Ratio|P/S Multiple AUNA (Auna S.A.)|SBC Medical Group Holdings Inc (SBC) - Price to Sales|EOLS - Price-to-Revenue Ratio|Market Capitalization-to-Revenue Ratio CYH (Community Health Systems Inc)|MDWD: P/S Multiple|BTMD: Market Cap to Sales Volume|Market Cap to Revenue JYNT|Price to Sales DocGo Inc. DCGO|PIII (P3 Health Partners, Inc.) - Price-to-Revenue Coefficient|GANX (Gain Therapeutics) - Market Capitalization-to-Revenue Ratio|P/S Multiple EUDA (EUDA Health Holdings)|BMGL (Basel Medical Group Limited) - Price-to-Sales Ratio|CLGN - Price-to-Revenue Ratio|Price to Sales cuprina.com.sg|CCM: P/S Multiple|AMS: Market Cap to Sales Volume|MRM (MEDIROM Corp) - P/S Multiple|ALBT: Market Capitalization-to-Revenue Ratio|P/S Multiple DHAI|Longevity Health Holdings - Market Cap to Revenue Ratio|Price-to-Revenue Ratio NewGenIvf Group Ltd NIVF|ATIP (atipt.com) - Price-to-Sales Ratio|CMAX: Market Cap to Revenue|Price to Sales Kindly Health|ModivCare (MODV) - Price-to-Revenue Ratio|NVOS (novointegrated.com) - Price-to-Revenue Ratio|SSY (SunLink Health Systems Inc.) - P/S Multiple|BACK (IMAC Holdings Inc) - Market Cap to Sales Volume